Shares of Aflac Incorporated (NYSE:AFL) have been assigned an average recommendation of “Hold” from the thirteen ratings firms that are covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among brokerages that have covered the stock in the last year is $51.83.
AFL has been the subject of a number of analyst reports. Zacks Investment Research raised Aflac from a “hold” rating to a “buy” rating and set a $56.00 price target for the company in a report on Friday, June 18th. boosted their price target on Aflac from $46.00 to $47.00 and gave the company a “sell” rating in a report on Monday, June 21st. Finally, Morgan Stanley boosted their price target on Aflac from $60.00 to $61.00 and gave the company an “overweight” rating in a report on Wednesday, May 19th.
NYSE AFL traded down $0.94 during trading hours on Tuesday, reaching $54.29. The stock had a trading volume of 2,497,195 shares, compared to its average volume of 3,326,321. The stock has a fifty day moving average of $55.17 and a 200 day moving average of $54.10. The stock has a market cap of $36.41 billion, a P/E ratio of 6.56, a price-to-earnings-growth ratio of 1.96 and a beta of 1.01. Aflac has a 52-week low of $33.37 and a 52-week high of $57.64. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.06 and a current ratio of 0.06.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 1st. Stockholders of record on Wednesday, August 18th were paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 2.43%. The ex-dividend date was Tuesday, August 17th. Aflac’s payout ratio is 26.61%.
In other news, Director Karole Lloyd acquired 1,000 shares of Aflac stock in a transaction that occurred on Friday, July 30th. The stock was purchased at an average cost of $55.21 per share, with a total value of $55,210.00. Following the purchase, the director now owns 37,035 shares in the company, valued at $2,044,702.35. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Charles D. Lake II sold 12,324 shares of the company’s stock in a transaction on Monday, June 28th. The shares were sold at an average price of $53.58, for a total value of $660,319.92. Following the completion of the sale, the director now owns 42,337 shares of the company’s stock, valued at $2,268,416.46. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 49,202 shares of company stock valued at $2,763,647. Corporate insiders own 1.50% of the company’s stock.
Large investors have recently modified their holdings of the business. KB Financial Partners LLC purchased a new stake in Aflac in the 1st quarter valued at $25,000. Solstein Capital LLC purchased a new position in shares of Aflac during the 1st quarter worth $26,000. Sterling Financial Planning Inc. purchased a new position in shares of Aflac during the 2nd quarter worth $27,000. Sumitomo Mitsui Financial Group Inc. purchased a new position in shares of Aflac during the 2nd quarter worth $27,000. Finally, West Branch Capital LLC purchased a new position in shares of Aflac during the 2nd quarter worth $34,000. Institutional investors own 66.29% of the company’s stock.
Aflac Company Profile
Aflac, Inc is a holding company, which engages in the provision financial protection services. It operates through the Aflac Japan and Aflac United States (U.S.) segments. The Aflac Japan segment offers life insurance, death benefits, and cash surrender values. The Aflac U.S. segment sells voluntary supplemental insurance products for people who already have major medical or primary insurance coverage.
Featured Story: How do investors use RSI to grade stocks?
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.